6/25/2025 Categories: Industries Angelini Industries: in 2024 net income up 30% to € 156 million. Group revenues (+3%) and EBITDA (+17%) also on the rise
5/11/2023 Categories: Health Angelini Pharma and JCR Pharmaceuticals Announce Global Collaboration for the Development and Commercialization of Novel Biologic Therapies in Epilepsy
11/21/2022 Categories: Pharma Angelini Industries appoints Jacopo Andreose new CEO of Angelini Pharma
9/29/2022 Categories: Pharma New Headway Report highlights environmental determinants of mental health
1/4/2021 Categories: Pharma Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments
Angelini Industries
